Shire rises on Astrazenca bid talk: traders
LONDON (Reuters) - Shares in Shire (SHP.L) gained 2.3 percent in brisk volume on Wednesday, bucking a weaker European stock market, with traders citing rehashed talk of a potential bid from UK-listed pharmaceutical peer AstraZeneca (AZN.L).
Shire's stock had traded 70 percent of its full-day volume average at 1341 GMT and it was among the top risers on the pan-European FTSEurofirst 300 index .FTEU3, down 0.3 percent.
AstraZeneca said it did not comment on market rumours, while Shire was unavailable for comment.
(Written by David Brett; Editing by Francesco Canepa)
- Sierra Leone's chief Ebola doctor contracts the virus
- Gaza bloodshed deepens as airlines shun Israel |
- Ukraine rebel commander acknowledges fighters had BUK missile
- TransAsia Airways plane crashes in typhoon-hit Taiwan, killing 47 |
- South Korea ferry fugitive hid behind cabin wall, bags of cash at hand